Aquestive Therapeutics, Inc. (AQST)
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$4.41
▲ +2.80%
Market Cap
$553.3M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.43
52-Wk Range
2.93-7.55
CEO
Daniel Barber
Country
US
Currency
USD
Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both the United States and international markets. The company's commercialized portfolio includes: Sympazan, an oral soluble film formulation of clobazam for individuals with Lennox-Gastaut syndrome. Suboxone, a sublingual film containing buprenorphine and naloxone, indicated for the treatment of opioid dependence. Zuplenz, an oral soluble film of ondansetron, used to manage nausea and vomiting associated with chemotherapy a…
Open full interactive analysis & DCF →